Skip to content

Efficacy and safety of two different types of platelet-rich plasma after rotator cuff tears: a randomized controlled trial

Efficacy and safety of two different types of platelet-rich plasma after rotator cuff tears: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089331
Enrollment
Unknown
Registered
2024-09-05
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injury

Interventions

lrprp injection group:lrprp injection+Arthroscopic rotator cuff repair
lpprp injection group:lpprp injection+Arthroscopic rotator cuff repair
Blank control group:Saline injection+Arthroscopic rotator cuff repair

Sponsors

Fujian provincial hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? The clinical symptoms are significant, affecting the daily life and work of patients; (2) Patients diagnosed with full-layer rotator cuff injury by shoulder MRI within 3 months and recommended with surgical indications according to the American Academy of Orthopaedic Surgeons (AAOS) rotator Cuff Clinical Practice Guidelines; ? Preoperative platelet > 150×109/L; ? Signed informed consent and good compliance.

Exclusion criteria

Exclusion criteria: ? Patients with bilateral rotator cuff injury requiring simultaneous surgery or a history of shoulder joint surgery; (2) According to the Cofield classification, it is defined as a large rotator cuff tear (the anterior and posterior diameter of the tear is greater than 5cm); ? Patients with upper limb fracture or severe nerve injury on the affected side; (4) Patients with severe shoulder joint osteoarthritis, autoimmune disease or serious organic disease.

Design outcomes

Primary

MeasureTime frame
vas score;ucla score;ases score;complications;Comprehensive satisfaction score;Retear condition;

Countries

china

Contacts

Public Contacthuiling Guo

Fujian provincial hospital

181308167@qq.com+86 181 5001 9516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026